Results
15
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
15 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
STMN | CHF 111.50 | 0.6% | -8.7% | CHF 17.8b | CHF 131.12 | PE61.8x | E20.9% | 0.8% | Healthcare | ||
VACN | CHF 343.70 | -1.0% | -9.5% | CHF 10.3b | CHF 420.53 | PE51.5x | E21.8% | 1.8% | Capital Goods | ||
SDZ | CHF 40.60 | 1.1% | 53.8% | CHF 17.8b | CHF 41.71 | PS2x | E34.5% | 1.1% | Pharmaceuticals & Biotech | ||
GALD | CHF 87.65 | 2.7% | n/a | CHF 20.8b | CHF 93.19 | PS5.4x | E44.4% | n/a | Pharmaceuticals & Biotech | ||
BAER | CHF 56.30 | 3.7% | 20.4% | CHF 11.5b | CHF 58.94 | PE30.8x | E22.5% | 4.6% | Diversified Financials | ||
LONN | CHF 521.40 | 1.8% | 48.8% | CHF 37.7b | CHF 631.85 | PE65.7x | E23.9% | 0.8% | Pharmaceuticals & Biotech | ||
SGSN | CHF 86.72 | 0.4% | 16.2% | CHF 16.2b | CHF 92.94 | PE29.5x | E11.9% | 3.7% | Commercial Services | ||
PGHN | CHF 1,263.50 | 2.6% | 10.3% | CHF 33.0b | CHF 1,281.40 | PE34.4x | E14.2% | 3.1% | Diversified Financials | ||
UBSG | CHF 28.30 | 0.8% | 21.4% | CHF 90.2b | CHF 29.59 | PE22.3x | E25.6% | 2.2% | Diversified Financials | ||
SREN | CHF 128.30 | 4.9% | 25.0% | CHF 37.3b | CHF 130.83 | PE14.2x | E12.8% | 4.7% | Insurance | ||
LOGN | CHF 71.02 | 2.6% | -4.7% | CHF 10.5b | CHF 81.88 | PE16.8x | E0.4% | 1.6% | Tech | ||
SOON | CHF 312.10 | -1.0% | 24.7% | CHF 18.6b | CHF 296.28 | PE32.9x | E11.2% | 1.4% | Healthcare | ||
EMSN | CHF 639.50 | 0.5% | 2.6% | CHF 15.0b | CHF 721.43 | PE32.4x | E8.8% | 2.5% | Materials | ||
GIVN | CHF 3,933.00 | 4.2% | 20.9% | CHF 36.3b | CHF 4,186.25 | PE35.2x | E6.1% | 1.7% | Materials | ||
ABBN | CHF 50.16 | 0.6% | 47.0% | CHF 92.3b | CHF 47.81 | PE26.6x | E9.2% | 1.7% | Capital Goods |